Innovation Days is a student invention competition open to all undergraduates at UW-Madison, that provides a platform to encourage them to explore and conduct self-directed research, outside the classroom environment. Students can compete for the Schoofs Prize for Creativity by pitching an original idea for a new invention, design or process via a poster presentation and a 10 minute oral/PowerPoint presentation in front of the judges. Those who are interested can also compete for the Tong Prototype Prize by going one step further and actually building a prototype of their idea. First prize for Schoofs is $10,000 and the Tong Prize is $2,500.
Related Insights
June 26, 2026
Health Care Law Today
California Attorney General Escalates Attack on PC-MSO Model: What Venture-Backed, Private Equity, and Digital Health Companies Need to Know
Foley & Lardner LLP (Foley) represented Carbon Health in negotiating a settlement agreement with the California Attorney General (AG) to resolve alleged corporate practice of medicine (CPOM) violations against Carbon Health, a technology-based primary and urgent care company that recently emerged from Chapter 11 bankruptcy.
June 26, 2026
Foley Viewpoints
17 States Challenge California Packaging Law With National Supply Chain Stakes
On June 22, 2026, 17 states, led by Nebraska, along with the National Association of Wholesaler-Distributors (NAW), sued California regulators and the Circular Action Alliance (CAA) in federal court, seeking to invalidate the state’s landmark packaging law, SB 54 (“SB 54” or “the Act”). The lawsuit, Nebraska v. Heller, is the first coordinated, multistate attack on the broader “extended producer responsibility” (EPR) model gaining traction for packaging regulation across the United States.
June 25, 2026
Foley Viewpoints
DOJ’s 2026 Health Care Fraud Takedown: Details Behind the Headline Number and What It Means for Health Care Providers
For health care companies, investors, management services organizations, provider platforms, and boards, the more important message is more specific: the government is now treating fast-growing reimbursement categories as data-driven, enterprise-risk environments.